MARKET

PPBT

PPBT

Purple Biotech Ltd
NASDAQ
0.5160
+0.0033
+0.64%
After Hours: 0.5700 +0.054 +10.47% 18:24 04/25 EDT
OPEN
0.5200
PREV CLOSE
0.5127
HIGH
0.6000
LOW
0.4900
VOLUME
1.69M
TURNOVER
0
52 WEEK HIGH
2.098
52 WEEK LOW
0.3023
MARKET CAP
13.41M
P/E (TTM)
-0.6551
1D
5D
1M
3M
1Y
5Y
Purple Biotech’s Cancer Study Shows Promise
TipRanks · 13h ago
Purple Biotech's Randomized Phase 2 CM24 Pancreatic Cancer Study Selected as Late-Breaking Abstract Poster Presentation at ASCO 2024 Annual Meeting
Interim data suggests reduced risk of progression or death in the CM24/nivolumab plus standard of care arm of the study. Purple Biotech is developing first-in-class therapies to overcome tumor immune evasion and drug resistance. The results will be presented at the 2024 American Society of Clinical Oncology Annual Meeting.
Barchart · 19h ago
12 Health Care Stocks Moving In Monday's After-Market Session
Nuwellis (NASDAQ:NUWE) stock rose 46.8% to $0.48 during Monday's after-market session. Sensei Biotherapeutics and Cognition Therapeutics among the gainers. Losers include Phio Pharma and Rigel Pharmaceuticals.
Benzinga · 3d ago
Weekly Report: what happened at PPBT last week (0415-0419)?
Weekly Report · 3d ago
Weekly Report: what happened at PPBT last week (0408-0412)?
Weekly Report · 04/15 09:42
Weekly Report: what happened at PPBT last week (0401-0405)?
Weekly Report · 04/08 09:44
Weekly Report: what happened at PPBT last week (0325-0329)?
Weekly Report · 04/01 09:44
Purple Biotech’s NT219 Shows Promising Cancer Fight
TipRanks · 03/28 11:59
More
About PPBT
Purple Biotech Ltd, formerly Kitov Pharma Ltd, is an Israel-based clinical-stage company that develops drugs that overcome tumor-immune evasion and drug resistancetreat pain. Main products of the Company is NT-219 i CM-24. CM-24 is a monoclonal antibody blockin and NT-219 is a small molecule bi-specific inhibitor of two key cancer resistance pathways. The Company is also the owner of Consensi, a fixed-dose combination of celecoxib and amlodipine besylate, for the simultaneous treatment of osteoarthritis pain and hypertension.

Webull offers Purple Biotech Ltd - ADR stock information, including NASDAQ: PPBT real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, PPBT stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading PPBT stock methods without spending real money on the virtual paper trading platform.